Company Profile

Axoneural Therapeutics Inc
Profile last edited on: 10/1/22      CAGE: 8MHM4      UEI: MBSCSV9D5SB5

Business Identifier: Nanoparticle-delivered drugs for treatment of traumatic spinal cord injury
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

10000 Cedar Avenue
Cleveland, OH 44106
   (216) 548-6968
Location: Single
Congr. District: 11

Public Profile

Originally founded in collaboration with Cleveland Clinic’s Lerner Research Institute with founding research and innovation from Cleveland Clinic, AxoNeural Therapeutics is described as structured around developing nanoparticle-delivered drugs for the treatment of traumatic spinal cord injury

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
Less than .5M
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $399,987
Project Title: Neupron™: a Neuroprotective Agent for Treating Acute Spinal Cord Injury

Key People / Management

  Vinod D Labhasetwar

  Satish Medicetty

  Akhil Saklecha -- Managing Director, Cleveland Clinic Ventures

Company News

There are no news available.